47 related articles for article (PubMed ID: 15877737)
1. Multiple myeloma with clivus involvement, neurological symptoms, and 45 g/L proteinorachia.
Chantran Y; Lavillegrand JR; Lefrere B; Gaillet A; Aucouturier P; Garderet L
Clin Case Rep; 2020 Jan; 8(1):5-8. PubMed ID: 31998476
[TBL] [Abstract][Full Text] [Related]
2. [A case-control study of multiple myeloma patients with central nervous system involvement].
Li L; Feng ZY; Guo P; He HY; Lu J; Liu J; Qiang WT; Jiang H; Du J; Fu WJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1016-1020. PubMed ID: 36709107
[No Abstract] [Full Text] [Related]
3. Multiple myeloma with t(11;14): unique biology and evolving landscape.
Bal S; Kumar SK; Fonseca R; Gay F; Hungria VT; Dogan A; Costa LJ
Am J Cancer Res; 2022; 12(7):2950-2965. PubMed ID: 35968339
[TBL] [Abstract][Full Text] [Related]
4. Secondary CNS myeloma with remission after systemic CNS-penetrating agents.
Fernandez LG; Oyon DE; Gondi V; Grimm S; Khan OH
Neurooncol Adv; 2022; 4(1):vdac106. PubMed ID: 35892045
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and outcomes of patients newly diagnosed with multiple myeloma with extramedullary disease].
Wang J; Zhang LN; Shi QL; Qu XY; Chen LJ; Li JY; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):822-828. PubMed ID: 33190439
[No Abstract] [Full Text] [Related]
6. Isolated central nervous system relapse of multiple myeloma post autologous stem cell transplant- A rare presentation.
Mittal A; Pushpam D; Kumar L
Leuk Res Rep; 2020; 14():100207. PubMed ID: 32566478
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma with central nervous system relapse.
Egan PA; Elder PT; Deighan WI; O'Connor SJM; Alexander HD
Haematologica; 2020 Jul; 105(7):1780-1790. PubMed ID: 32414852
[TBL] [Abstract][Full Text] [Related]
8. CD56-positive diffuse large B-cell lymphoma/leukemia with
Liu Y; Shen J; Awal Issah M; Liu T; Zhou H; Fu H
J Int Med Res; 2020 May; 48(5):300060520918087. PubMed ID: 32363958
[TBL] [Abstract][Full Text] [Related]
9. Intracranial Involvement in Multiple Myeloma Presenting as a Cranial Nerve Palsy.
Fitzgerald E; Kiely P; Leary HO
J Hematol; 2019 Mar; 8(1):29-33. PubMed ID: 32300438
[TBL] [Abstract][Full Text] [Related]
10. Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review.
Bergantim R; Bastos J; Soares MJ; Carvalho B; Soares P; Marques C; Costa J; Guimarães JE; Trigo F
Case Rep Hematol; 2020; 2020():8563098. PubMed ID: 31984141
[TBL] [Abstract][Full Text] [Related]
11. Extramedullary multiple myeloma.
Bhutani M; Foureau DM; Atrash S; Voorhees PM; Usmani SZ
Leukemia; 2020 Jan; 34(1):1-20. PubMed ID: 31776467
[TBL] [Abstract][Full Text] [Related]
12. Hepatic manifestations in hematological disorders.
Murakami J; Shimizu Y
Int J Hepatol; 2013; 2013():484903. PubMed ID: 23606974
[TBL] [Abstract][Full Text] [Related]
13. Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases.
Duenisch P; Reichart R; Mueller U; Brodhun M; Bjerkvig R; Romeike B; Walter J; Herbold C; Regenbrecht CR; Kalff R; Kuhn SA
J Cancer Res Clin Oncol; 2011 Mar; 137(3):399-414. PubMed ID: 20440511
[TBL] [Abstract][Full Text] [Related]
14. Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.
Micallef J; Dharsee M; Chen J; Ackloo S; Evans K; Qiu L; Chang H
J Hematol Oncol; 2010 Apr; 3():13. PubMed ID: 20374647
[TBL] [Abstract][Full Text] [Related]
15. Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors.
Todaro L; Christiansen S; Varela M; Campodónico P; Pallotta MG; Lastiri J; Sacerdote de Lustig E; Bal de Kier Joffé E; Puricelli L
J Neurooncol; 2007 Jun; 83(2):135-44. PubMed ID: 17216340
[TBL] [Abstract][Full Text] [Related]
16. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
18. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
19. A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report.
Gozzetti A; Cerase A; Crupi R; Raspadori D; Defina M; Bocchia M; Lauria F
Leuk Res; 2011 Nov; 35(11):e206-8. PubMed ID: 21767877
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
